This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/investors-channel-over-150-billion-into-coronavirus-bonds-11591178004

Investors Channel Over $150 Billion Into Coronavirus Bonds

Pfizer and Bank of America are among the companies that have tapped investors since February

By

Anna Hirtenstein

Companies and laboratories are racing to develop a coronavirus vaccine that would help society get back to normal. But there could be costs to moving too quickly.

The coronavirus pandemic has led to the genesis of a new class of bonds, paving the way for fund managers to springboard from socially responsible investing to putting money toward the health crisis.

Governments, banks, companies and multinational organizations raised $151.5 billion globally by May 31 from selling Covid-19 bonds, or debt whose proceeds are broadly earmarked for work linked to the pandemic, according to research by BNP Paribas.

Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Further Reading

Universities Close Offices, Halt Research in Response to Trump’s Ban on DEI

Advertisement